denkapparat Operations GmbH Takes Position in Corteva, Inc. $CTVA

denkapparat Operations GmbH bought a new position in shares of Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 12,698 shares of the company’s stock, valued at approximately $1,075,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. acquired a new position in Corteva during the 2nd quarter valued at about $4,560,180,000. Harris Associates L P increased its holdings in Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after purchasing an additional 10,675,052 shares in the last quarter. Norges Bank purchased a new stake in shares of Corteva in the fourth quarter worth approximately $504,001,000. Wellington Management Group LLP raised its stake in shares of Corteva by 941.7% in the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after purchasing an additional 6,881,875 shares during the last quarter. Finally, Jupiter Topco LLC bought a new position in shares of Corteva in the second quarter valued at approximately $544,246,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

CTVA stock opened at $88.71 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm has a market cap of $59.19 billion, a PE ratio of 58.75, a P/E/G ratio of 2.76 and a beta of 0.57. The business has a 50 day moving average of $83.31 and a 200-day moving average of $80.96. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same period last year, the company posted $2.20 earnings per share. Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, sell-side analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Analysts Set New Price Targets

CTVA has been the topic of several analyst reports. Citigroup lifted their target price on Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Bank of America raised their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research note on Monday, July 20th. CICC Research lifted their price objective on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. UBS Group reduced their target price on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating for the company in a research note on Tuesday, August 18th. Finally, Oppenheimer increased their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.